announces

Hill’s Pet Nutrition Announces 2025 Hill’s Global Symposium – “Strong Science, Long Lives” – to Advance Senior Pet Care

Registration now open for veterinary professionals in Asia and Australia to access the latest insights in geroscience and nutritional strategies…

2 months ago

CathWorks Announces Key Events for TCT 2025

The CathWorks FFRangio® System to be Center Stage, Featured in Multiple Scientific Sessions, Live Cases and a Primetime Academic Satellite…

2 months ago

HearAdvisor Announces New Guide on the Best Hearing Aids and Earplugs of 2025 with Expert Choice Awards

October 22, 2025 17:59 ET  | Source: HearAdvisor Rockford, Il, Oct. 22, 2025 (GLOBE NEWSWIRE) -- HearAdvisor, an independent audio…

2 months ago

THE GENESIS FACADE COMMISSION AT THE METROPOLITAN MUSEUM OF ART ANNOUNCES LIU WEI AS THE ARTIST FOR 2026

Beijing-based artist Liu Wei selected for next year’s The Genesis Facade Commission at The Metropolitan Museum of Art in New…

2 months ago

Alps Blockchain Announces Corporate Rebranding to Alps

Reflecting its evolution into a global builder of next-generation data center infrastructure powering Bitcoin and, in the future, AI computation TRENTO,…

2 months ago

Aveanna Announces Pricing of Secondary Offering of Common Stock

ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused…

2 months ago

Sotera Health Announces Third-Quarter 2025 Earnings Release Date

CLEVELAND, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization…

2 months ago

IDI Announces Integration with TazWorks to Expand Access to IDIs Best-in-Class Identity Intelligence in the Background Screening Industry

October 21, 2025 12:21 ET  | Source: Interactive Data, LLC BOCA RATON, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Interactive…

2 months ago

SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology

Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response…

2 months ago

Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Companys Ongoing Transformation

Intention follows comprehensive strategic review process and would represent the optimal capital allocation pathway to support a stronger and sustainable…

2 months ago